Corcept Therapeutics
Develops cortisol-modulating medicines for endocrine disease and cancer.
$115.08
After-hours close+1.21 (+1.06%)
At close$113.87(−2.62%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.81 | — | — |
| Jul 2026 | $0.02 | $0.36 | +1,383.3% |
| Apr 2026 | −$0.14 | −$0.30 | −111.3% |
| Feb 2026 | $0.33 | $0.20 | −39.4% |
| Nov 2025 | $0.18 | $0.16 | −11.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | $0.81 | — | — | $323.9M | — | — |
| Jul 29, 2026 | $0.02 | $0.36 | +1,383.3% | $221.1M | $256.1M | +15.8% |
| Apr 30, 2026 | −$0.14 | −$0.30 | −111.3% | $185.3M | $164.9M | −11.0% |
| Feb 24, 2026 | $0.33 | $0.20 | −39.4% | $254.9M | $202.1M | −20.7% |
| Nov 4, 2025 | $0.18 | $0.16 | −11.1% | $255.3M | $207.6M | −18.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 31, 2025 | ||||||
| May 5, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Oct 30, 2024 | ||||||
| Jul 29, 2024 | ||||||
| May 1, 2024 | ||||||
| Feb 15, 2024 | ||||||
| Nov 1, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 3, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 3, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 15, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Jul 29, 2021 | ||||||
| May 6, 2021 | ||||||
| Feb 23, 2021 | ||||||
| Nov 3, 2020 | ||||||
| Aug 4, 2020 | ||||||
| May 4, 2020 | ||||||
| Feb 20, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 1, 2019 | ||||||
| May 9, 2019 | ||||||
| Feb 25, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 8, 2018 | ||||||
| Feb 22, 2018 | ||||||
| Nov 2, 2017 | ||||||
| Aug 1, 2017 | ||||||
| May 1, 2017 | ||||||
| Mar 6, 2017 | ||||||
| Nov 1, 2016 | ||||||
| Aug 2, 2016 | ||||||
| May 3, 2016 | ||||||
| Mar 1, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 5, 2015 | ||||||